Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

NCT04771143 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study terminated/withdrawn before FPFV (no patients enrolled)

Conditions

Cocaine Use Disorder

Interventions

DRUG: AFQ056
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]